Usa Eu World Coronavirus Usa Eu

EU reviews J&J vaccine for rare nerve disorder after US warning

Reading now: 894
www.rte.ie

The European Medicines Agency (EMA) said it was analysing data on rare cases of a nerve disorder reported among recipients of Janssen (Johnson & Johnson's) Covid-19 vaccine, after the United States added a warning label to the shot.

The "EMA's safety committee (PRAC) is analysing data provided by (J&J) ... on cases of Guillain-Barre syndrome (GBS) reported following vaccination," the European medicine regulator said in a statement to Reuters. "PRAC has requested (Johnson & Johnson) to provide further detailed data." The EMA scrutiny comes after the US Food and Drug Administration (FDA) yesterday added a warning for GBS to the fact sheet for J&J's shot, and after the EMA four days ago included a warning for AstraZeneca's Covid-19 shot for

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA